EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study

Labrinus van Manen iD, Lizzie D A N de Muynck, Victor M Baart, Shadhvi Bhairosingh, Pieterjan Debie iD, Alexander L Vahrmeijer, Sophie Hernot iD, J Sven D Mieog

Biomolecules · 2023

DOI: 10.3390/biom13040618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Labrinus van Manen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands organization for health research and development, ITEA 3 Call 4, Industrial research fund of the Vrije Universiteit Brussel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular fluorescence-guided surgery using near-infrared light has the potential to improve the rate of complete resection of cancer. Typically, monoclonal antibodies are being used as targeting moieties, however smaller fragments, such as single-domain antibodies (i.e., Nanobodies®) improve tumor specificity and enable tracer injection on the same day as surgery. In this study, the feasibility of a carcinoembryonic antigen-targeting Nanobody (NbCEA5) conjugated to two zwitterionic dyes (ZW800-1 Forte [ZW800F] and ZW800-1) for visualization of pancreatic ductal adenocarcinoma (PDAC) was investigated. After site-specific conjugation of NbCEA5 to the zwitterionic dyes, binding specificity was evaluated on human PDAC cell lines with flow cytometry. A dose escalation study was performed for both NbCEA5-ZW800F and NbCEA5-ZW800-1 in mice with subcutaneously implanted pancreatic tumors. Fluorescence imaging was performed up to 24 h after intravenous injection. Furthermore, the optimal dose for NbCEA5-ZW800-1 was injected in mice with orthotopically implanted pancreatic tumors. A dose-escalation study showed superior mean fluorescence intensities for NbCEA5-ZW800-1 compared to NbCEA5-ZW800F. In the orthotopic tumor models, NbCEA5-ZW800-1 accumulated specifically in pancreatic tumors with a mean in vivo tumor-to-background ratio of 2.4 (SD = 0.23). This study demonstrated the feasibility and potential advantages of using a CEA-targeted Nanobody conjugated to ZW800-1 for intraoperative PDAC imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansAnimalsMiceCarcinoembryonic AntigenOptical ImagingColoring AgentsCell Line, Tumor

Stichwörter der Autor:innen

antibodyfluorescencenanobodynear-infraredpancreatic cancerpancreatic ductal adenocarcinomasurgeryzwitterionic

Substanzen

Carcinoembryonic AntigenColoring Agents

Autor:innen und Institutionen

  • Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Laboratory for In Vivo Cellular and Molecular Imaging (ICMI-MIMA/BEFY), Vrije Universiteit Brussel, 1050 Brussels, Belgium.

ORCID-Profile: Labrinus van Manen, Pieterjan Debie, Sophie Hernot

Förderung

  • Netherlands organization for health research and development
  • ITEA 3 Call 4
  • Industrial research fund of the Vrije Universiteit Brussel

Zitieren

APA

van Manen, L., de Muynck, L. D. A. N., Baart, V. M., Bhairosingh, S., Debie, P., Vahrmeijer, A. L., Hernot, S., & Mieog, J. S. D. (2023). Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study. Biomolecules. https://doi.org/10.3390/biom13040618

Vancouver

van Manen L, de Muynck LDAN, Baart VM, Bhairosingh S, Debie P, Vahrmeijer AL, et al. Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study. Biomolecules. 2023. doi:10.3390/biom13040618

BibTeX
@article{vanManen2023,
  author = {van Manen, Labrinus and de Muynck, Lizzie D A N and Baart, Victor M and Bhairosingh, Shadhvi and Debie, Pieterjan and Vahrmeijer, Alexander L and Hernot, Sophie and Mieog, J Sven D},
  title = {Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13040618}
}
Kostenlos starten →